On July 23, 2026, in Parsippany, New Jersey, Embecta Corp. (Nasdaq: EMBC) announced its plans to host a conference call on August 7, 2026, at 8:00 a.m. Eastern Time. The call will focus on discussing the company's fiscal third-quarter 2026 financial results, offering an operational update, and including a question and answer session. Embecta Corp., a global entity with a 100-year heritage in insulin delivery, is currently in transition to diversify and become a comprehensive medical supplies provider.